Literature DB >> 10553715

The quinolones and renal infection.

A Ronald1.   

Abstract

The fluoroquinolones are excellent drugs for the treatment of most patients with renal infection. Ciprofloxacin has proved its value in good clinical trials for uncomplicated acute pyelonephritis and has been used widely for complicated urinary tract infections with presumed renal infection.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10553715     DOI： 10.2165/00003495-199958002-00019

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


  10 in total

1.  Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.

Authors:  G J Sheehan; G K Harding; D A Haase; M J Thomson; B Urias; J K Kennedy; D J Hoban; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

2.  Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis.

Authors:  T Sandberg; G Englund; K Lincoln; L G Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

3.  Pyelonephritis in adult women: inpatient versus outpatient therapy.

Authors:  S Safrin; D Siegel; D Black
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

4.  Complicated urinary tract infections.

Authors:  A R Ronald; G K Harding
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 5.  Diagnosis and treatment of uncomplicated urinary tract infection.

Authors:  T M Hooton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 6.  Management of urinary tract infections in adults.

Authors:  W E Stamm; T M Hooton
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

7.  Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis.

Authors:  R R Bailey; K L Lynn; R A Robson; B A Peddie; A Smith
Journal:  N Z Med J       Date:  1992-03-25

8.  A critical evaluation of nalidixic acid in urinary-tract infections.

Authors:  A R Ronald; M Turck; R G Petersdorf
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

9.  A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae.

Authors:  J K Preiksaitis; L Thompson; G K Harding; T J Marrie; S Hoban; A R Ronald
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

10.  Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.

Authors:  G L Drusano; D E Johnson; M Rosen; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191
  10 in total
  1 in total

1.  Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens.

Authors:  Orhiosefe Omigie; Lawrence Okoror; Patience Umolu; Gladys Ikuuh
Journal:  Int J Gen Med       Date:  2009-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.